A detailed history of Gamma Investing LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Gamma Investing LLC holds 1,428 shares of COLL stock, worth $49,266. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,428
Previous 636 124.53%
Holding current value
$49,266
Previous $20.5 Million 169.44%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$31.4 - $39.07 $24,868 - $30,943
792 Added 124.53%
1,428 $55.2 Million
Q2 2024

Jul 02, 2024

BUY
$31.36 - $39.99 $8,247 - $10,517
263 Added 70.51%
636 $20.5 Million
Q1 2024

Apr 05, 2024

BUY
$31.23 - $40.91 $5,090 - $6,668
163 Added 77.62%
373 $14.5 Million
Q4 2023

Feb 01, 2024

BUY
$21.16 - $30.8 $4,443 - $6,468
210 New
210 $6.92 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.18B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.